| David S Fagan, MD | |
|
101 Boulder Point Dr, Suite 1, Plymouth, NH 03264-3170 | |
| (603) 536-4000 | |
| (603) 536-4001 |
| Full Name | David S Fagan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 101 Boulder Point Dr, Plymouth, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841220423 | NPI | - | NPPES |
| 11P018 | Other | VT | MVP |
| FAGA18669 | Other | VT | VT BC BS |
| 137310 | Other | PA | CIGNA SCRANTON |
| ANTHEM | Other | NH | BLUE CROSS BLUE SHIELD |
| 110095743 | Other | RRMCR | |
| 2165 | Medicaid | VT | |
| 80002165 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | NH8707 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pemi Baker Community Health | Plymouth, NH | Home health agency |
| North Country Home Health & Hospice Agency | Littleton, NH | Home health agency |
| Lakes Region Visiting Nurse Association | Meredith, NH | Home health agency |
| Speare Memorial Hospital | Plymouth, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-state Health Center | 1951363563 | 33 |
News Archive
The road to death or differentiation follows a similar course in embryonic stem cells, said researchers at Baylor College of Medicine in Houston in a report that appears online today in the journal Cell Stem Cell.
MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it has launched its Health Insurance Exchange offerings to help states address the federal regulatory requirements under the Affordable Care Act (ACA).
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
Even though parents may smoke only outside and away from their infant, babies apparently still absorb dangerous chemicals from them.
› Verified 6 days ago
| Entity Name | Mid-state Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235170549 PECOS PAC ID: 1951363563 Enrollment ID: O20041027000215 |
News Archive
The road to death or differentiation follows a similar course in embryonic stem cells, said researchers at Baylor College of Medicine in Houston in a report that appears online today in the journal Cell Stem Cell.
MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it has launched its Health Insurance Exchange offerings to help states address the federal regulatory requirements under the Affordable Care Act (ACA).
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
Even though parents may smoke only outside and away from their infant, babies apparently still absorb dangerous chemicals from them.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David S Fagan, MD 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264-3170 Ph: (603) 536-4000 | David S Fagan, MD 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264-3170 Ph: (603) 536-4000 |
News Archive
The road to death or differentiation follows a similar course in embryonic stem cells, said researchers at Baylor College of Medicine in Houston in a report that appears online today in the journal Cell Stem Cell.
MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it has launched its Health Insurance Exchange offerings to help states address the federal regulatory requirements under the Affordable Care Act (ACA).
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
Even though parents may smoke only outside and away from their infant, babies apparently still absorb dangerous chemicals from them.
› Verified 6 days ago
Frederick S Kelsey, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264 Phone: 603-536-4000 Fax: 603-536-4001 | |
Dr. Linda M Crawford, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7 Artisan Ln, Plymouth, NH 03264 Phone: 603-536-5665 | |
Dana A Merrithew, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 103 Boulder Point Drive, Plymouth, NH 03264 Phone: 603-536-1881 Fax: 603-238-2198 | |
Dr. John J Jehl, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Hospital Road, Speare Hospitalist Program, Plymouth, NH 03264 Phone: 603-536-1120 Fax: 603-536-4828 | |
Alexandria Sarah Raifsnider, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 19 Highland Ave, Plymouth, NH 03264 Phone: 603-393-1130 |